Page last updated: 2024-09-04

moxifloxacin and colistin

moxifloxacin has been researched along with colistin in 4 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(colistin)
Trials
(colistin)
Recent Studies (post-2010) (colistin)
3,1575521,6905,4491983,262

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E1
Erdogan-Yildirim, Z; Manafi, M; Sauermann, R; Schwameis, R; Strommer, S; Zeitlinger, MA1
Aguilera-Correa, JJ; Carias-Cálix, RA; Esteban, J; Gisbert-Garzarán, M; Jiménez-Jiménez, C; Mediero, A; Vallet-Regí, M1
Agrawal, D; Chatterjee, S; Gangwe, AB; Gomase, SN; Mishra, M; Parchand, SM1

Other Studies

4 other study(ies) available for moxifloxacin and colistin

ArticleYear
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins

2001
Effect of pulmonary surfactant on antimicrobial activity in vitro.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Acetamides; Animals; Anti-Infective Agents; Aza Compounds; Carbapenems; Colistin; Daptomycin; Doripenem; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Oxazolidinones; Pulmonary Surfactants; Quinolines; Staphylococcus aureus; Swine; Tigecycline

2013
Arabic gum plus colistin coated moxifloxacin-loaded nanoparticles for the treatment of bone infection caused by Escherichia coli.
    Acta biomaterialia, 2022, 01-01, Volume: 137

    Topics: Animals; Anti-Bacterial Agents; Colistin; Escherichia coli; Moxifloxacin; Nanoparticles; Osteomyelitis; Rabbits; Silicon Dioxide

2022
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
    Indian journal of ophthalmology, 2022, Volume: 70, Issue:12

    Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifloxacin; Humans; Longitudinal Studies; Moxifloxacin; Ofloxacin; Retrospective Studies

2022